Advertisement
Screener

NeuroOne Medical Technologies Corporation (NMTC) Amortization of Debt Discount (Premium)

NeuroOne Medical Technologies Corporation Amortization of Debt Discount (Premium)

NeuroOne Medical Technologies Corporation (NMTC) reported Amortization of Debt Discount (Premium) of $233.22 thousand for the 3-month period ending 2018-12-31, per its 10-Q filed 2019-02-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:AmortizationOfDebtDiscountPremium · last filed 2019-03-18

  • NeuroOne Medical Technologies Corporation amortization of debt discount (premium) for the quarter ending 2018-12-31 was $233.22K, a 21.90% decline year-over-year.
  • NeuroOne Medical Technologies Corporation amortization of debt discount (premium) for the quarter ending 2018-09-30 was $233.99K, a 49.23% decline year-over-year.
  • NeuroOne Medical Technologies Corporation amortization of debt discount (premium) for the quarter ending 2018-06-30 was $238.11K, a 21.67% decline year-over-year.
  • NeuroOne Medical Technologies Corporation amortization of debt discount (premium) for the quarter ending 2018-03-31 was $138.92K, a 22.19% decline year-over-year.
  • NeuroOne Medical Technologies Corporation amortization of debt discount (premium) for fiscal 2017 was $1.24M.
Period endAmortization of Debt Discount (Premium) 3 monthAmortization of Debt Discount (Premium) 6 monthAmortization of Debt Discount (Premium) 9 monthAmortization of Debt Discount (Premium) 12 month
2018-12-31$233.22K
10-Q · filed 2019-02-14
$467.22K
derived: sum of 2 quarters · filed 2019-03-18
$705.33K
derived: sum of 3 quarters · filed 2019-03-18
$844.24K
derived: sum of 4 quarters · filed 2019-03-18
2018-09-30$233.99K
derived: 10-KT 9 month − 10-Q 6 month · filed 2019-03-18
$472.10K
derived: sum of 2 quarters · filed 2019-03-18
$611.02K
10-KT · filed 2019-03-18
$909.63K
derived: sum of 4 quarters · filed 2019-03-18
2018-06-30$238.11K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
$377.03K
10-Q · filed 2018-08-13
$675.63K
derived: sum of 3 quarters · filed 2019-02-14
$1.14M
derived: sum of 4 quarters · filed 2019-03-18
2018-03-31$138.92K
10-Q · filed 2018-05-16
$437.52K
derived: sum of 2 quarters · filed 2019-02-14
$898.45K
derived: sum of 3 quarters · filed 2019-03-18
$1.20M
derived: sum of 4 quarters · filed 2019-03-18
2017-12-31$298.61K
10-Q · filed 2019-02-14
$759.53K
derived: sum of 2 quarters · filed 2019-03-18
$1.06M
derived: sum of 3 quarters · filed 2019-03-18
$1.24M
10-KT · filed 2019-03-18
2017-09-30$460.92K
derived: 10-KT 9 month − 10-Q 6 month · filed 2019-03-18
$764.89K
derived: sum of 2 quarters · filed 2019-03-18
$943.43K
10-KT · filed 2019-03-18
2017-06-30$303.96K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
$482.50K
10-Q · filed 2018-08-13
2017-03-31$178.54K
10-Q · filed 2018-05-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
Picard Medical, Inc. (PMI)United States$0.011B-0.01
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
CERENOME, INC. (CNSY)United States$0.014B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Modular Medical, Inc. (MODD)United States$0.018B-0.88
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B